Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma

被引:23
作者
Boonstra, R
Bosga-Bouwer, A
Mastik, M
Haralambieva, E
Conradie, J
van den Berg, E
van den Berg, A
Poppema, S
机构
[1] Univ Groningen Hosp, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Genet, NL-9700 RB Groningen, Netherlands
关键词
transformation; comparative genomic; hybridization; follicular lymphoma; large B-cell lymphoma;
D O I
10.1016/S0046-8177(03)00350-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The histological transformation from a follicular lymphoma (FL) to a diffuse large B-cell lymphoma (DLBL) occurs in 22% to 30% of all cases of FL. The aim of this study was to identify specific chromosomal gains/losses associated with transformation of FL to DLBL, in addition to the well-known mechanisms like p53 mutation and protein expression and c-myc translocation and up-regulation. This is the first study to meet 2 important conditions for such a comparison. First, we demonstrate that the FL and the DLBL were clonally related, based on identical immunoglobulin gene rearrangements in 5 of the 6 cases. Second, we used laser microdissection microscopy to isolate only the neoplastic cells from the initial FL samples. The results indicate that no single chromosomal abnormality seems to be responsible for the transformation of FL to DLBL. P53 protein overexpression was found in 4 and c-myc translocation in 3 of the 6 transformed DLBLs, but not in the initial FL samples. Additional chromosomal abnormalities were detected by comparative genomic hybridization in all 6 cases when the DLBL was compared with the FL. In the 5 cases with transformation of grade 1 or 2 FL to DLBL, gains at chromosomes 7 (5 of 5 cases), 10p1 (3 of 5 cases), 12 (3 of 5 cases), and 20p13 (2 of 5 cases) and loss at 9q (4 of 5 cases) were the most frequently found abnormalities. A gain on chromosome 7p, in combination with a loss on 9q, was found in 4 of the 5 DLBL that transformed from FL grade 1 or 2. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:915 / 923
页数:9
相关论文
共 38 条
  • [1] Arcinas M, 2001, CANCER RES, V61, P5202
  • [2] CORRELATION OF SECONDARY CYTOGENETIC ABNORMALITIES WITH HISTOLOGIC APPEARANCE IN NON-HODGKINS LYMPHOMAS BEARING T(14, 18)(Q32, Q21)
    ARMITAGE, JO
    SANGER, WG
    WEISENBURGER, DD
    HARRINGTON, DS
    LINDER, J
    BIERMAN, PJ
    VOSE, JM
    PURTILO, DT
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (08) : 576 - 580
  • [3] CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18
    BAKHSHI, A
    JENSEN, JP
    GOLDMAN, P
    WRIGHT, JJ
    MCBRIDE, OW
    EPSTEIN, AL
    KORSMEYER, SJ
    [J]. CELL, 1985, 41 (03) : 899 - 906
  • [4] Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients
    Bastion, Y
    Sebban, C
    Berger, F
    Felman, P
    Salles, G
    Dumontet, C
    Bryon, PA
    Coiffier, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1587 - 1594
  • [5] Gain of chromosome 7, which marks the progression from indolent to aggressive follicle centre lymphomas, is restricted to the B-lymphoid cell lineage: a study by FISH in combination with morphology and immunocytochemistry
    Bernell, P
    Arvidsson, I
    Jacobsson, B
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) : 1140 - 1144
  • [6] DIFFUSE LARGE-CELL LYMPHOMAS EXHIBIT FREQUENT DELETIONS IN 9P21-22 AND 9Q31-34 REGIONS
    CHAGANTI, SR
    GAIDANO, G
    LOUIE, DC
    DALLAFAVERA, R
    CHAGANTI, RSK
    [J]. GENES CHROMOSOMES & CANCER, 1995, 12 (01) : 32 - 36
  • [7] Cooper K, 1997, J PATHOL, V182, P307
  • [8] Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma
    Elenitoba-Johnson, KSJ
    Gascoyne, RD
    Lim, MS
    Chhanabai, M
    Jaffe, ES
    Raffeld, M
    [J]. BLOOD, 1998, 91 (12) : 4677 - 4685
  • [9] GARVIN AJ, 1983, CANCER-AM CANCER SOC, V52, P393, DOI 10.1002/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO
  • [10] 2-M